Combined with MA-induced endothelial activation, upregulation of procoagulant mediators such as tissue factor and plasminogen activator inhibitor-1 (PAI-1), and enhanced platelet aggregation, contributing to a prothrombotic state that increases the risk of LVT and cardioembolic stroke [7,9,14,15]. This evidence concerns the gene SERPINE1 and cardioembolic stroke.